A Fitzgerald team paper was published in The Lancet on a study which investigated whether offering the Cytosponge-TFF3 test to patients on medication for gastro-oesophageal reflux would increase the detection of Barrett's oesophagus compared with standard management. You can read the paper here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31099-0/fulltext
